Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) Short Interest Update

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) saw a large growth in short interest during the month of June. As of June 30th, there was short interest totaling 4,249 shares, a growth of 94.6% from the June 15th total of 2,184 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily volume of 11,212 shares, the days-to-cover ratio is currently 0.4 days.

Hedge Funds Weigh In On Aimei Health Technology

Hedge funds have recently modified their holdings of the business. Clear Street Group Inc. grew its stake in shares of Aimei Health Technology by 36.5% in the fourth quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock worth $5,334,000 after purchasing an additional 22,294 shares during the last quarter. Quarry LP lifted its holdings in Aimei Health Technology by 6.4% during the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock worth $1,891,000 after buying an additional 10,000 shares during the period. Geode Capital Management LLC acquired a new position in Aimei Health Technology during the 4th quarter worth about $413,000. Dakota Wealth Management bought a new stake in shares of Aimei Health Technology in the 4th quarter valued at about $406,000. Finally, Jane Street Group LLC bought a new stake in shares of Aimei Health Technology in the 4th quarter valued at about $302,000. Institutional investors and hedge funds own 45.58% of the company’s stock.

Aimei Health Technology Stock Down 1.8%

Shares of AFJK stock traded down $0.21 during mid-day trading on Friday, reaching $11.79. 638 shares of the stock traded hands, compared to its average volume of 20,703. The company has a market cap of $37.36 million, a price-to-earnings ratio of 73.67 and a beta of 0.55. The stock’s fifty day simple moving average is $33.01 and its two-hundred day simple moving average is $40.04. Aimei Health Technology has a 1-year low of $6.75 and a 1-year high of $130.37.

Aimei Health Technology (NASDAQ:AFJK) last issued its quarterly earnings data on Tuesday, June 16th. The company reported $0.01 earnings per share (EPS) for the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Aimei Health Technology in a research note on Wednesday, June 24th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.